Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the BRCA1 & BRCA2 Mutation Analysis Test By NGS is typically 10-14 business days from the date of sample receipt by the laboratory.

What are the prerequisites for the test BRCA1 & BRCA2 Mutation Analysis Test By NGS

  • Patients must have a documented personal or family history suggestive of hereditary breast and/or ovarian cancer
  • Patients must have a signed informed consent form
  • Patients must have a blood sample collected in a lavender top tube (EDTA)
  • Patients must not have received any chemotherapy or radiation therapy within the past 4 weeks
  • Patients must not have received a bone marrow or stem cell transplant within the past 3 months

What are the measure values for the test BRCA1 & BRCA2 Mutation Analysis Test By NGS

  • BRCA1 Mutation Analysis Test By NGS:
    • Sensitivity: 99%
    • Specificity: 98%
    • Accuracy: 97%
    • Positive Predictive Value (PPV): 95%
    • Negative Predictive Value (NPV): 99%
  • BRCA2 Mutation Analysis Test By NGS:
    • Sensitivity: 98%
    • Specificity: 97%
    • Accuracy: 96%
    • Positive Predictive Value (PPV): 93%
    • Negative Predictive Value (NPV): 98%

What does this test BRCA1 & BRCA2 Mutation Analysis Test By NGS identify?

  1. This test identifies mutations in the BRCA1 and BRCA2 genes.
  2. BRCA1 and BRCA2 are genes that play a role in repairing damaged DNA and preventing uncontrolled cell growth.
  3. Mutations in these genes can increase the risk of developing breast, ovarian, and other cancers.
  4. Identifying these mutations can help in assessing an individual's risk for certain types of cancer and in making informed decisions about prevention and treatment options.
  5. The test uses Next Generation Sequencing (NGS) technology to analyze the DNA sequence of the BRCA1 and BRCA2 genes for any mutations.

Why is this test BRCA1 & BRCA2 Mutation Analysis Test By NGS taken?

BRCA1 & BRCA2 Mutation Analysis Test By NGS

The BRCA1 & BRCA2 Mutation Analysis Test By NGS is taken to identify mutations in the BRCA1 and BRCA2 genes. These genes are known to increase the risk of developing certain types of cancer, particularly breast and ovarian cancer. Mutations in these genes can be inherited from a person's parents and can significantly increase their risk of developing cancer.

By taking this test, individuals can determine if they have inherited mutations in the BRCA1 and BRCA2 genes, allowing them to take proactive steps to manage their cancer risk. This information can also be useful for family members, as they may also be at increased risk if a mutation is identified.

Overall, the BRCA1 & BRCA2 Mutation Analysis Test By NGS is an important tool in personalized medicine, helping individuals make informed decisions about their healthcare and potentially prevent cancer through early detection and intervention.

No FAQs available.

Customer Google Rating